Open Peer Review Reports for: A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 23 Jan 2002 | Submitted | Original manuscript |
| 23 Jan 2002 | Author responded | Author comments - Sean Curtis |
| Resubmission - Version 2 | ||
| 23 Jan 2002 | Submitted | Manuscript version 2 |
| 11 Feb 2002 | Reviewed | Reviewer Report - Max Bulsara |
| 23 Mar 2002 | Reviewed | Reviewer Report - Joanne van Ryn |
| 22 Apr 2002 | Author responded | Author comments - Sean Curtis |
| Resubmission - Version 3 | ||
| 22 Apr 2002 | Submitted | Manuscript version 3 |
| Publishing | ||
| 22 May 2002 | Editorially accepted | |
| 22 May 2002 | Article published | 10.1186/1471-2296-3-10 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
